Aurobindo Pharma’s arm gets GMP certificate of compliance for Hyderabad facility

13 Nov 2024 Evaluate

Aurobindo Pharma’s wholly owned subsidiary -- CuraTeQ Biologics has received a Good Manufacturing Practice (GMP) certificate of compliance for its biosimilars manufacturing facility in Hyderabad, from the European Medicines Agency (EMA). 

The GMP inspection, conducted by EMA representatives from April 8 to April 12, 2024, assessed mammalian and microbial drug substance manufacturing facility sections, prefilled syringes and vials filling, packaging, and QC testing and release laboratories.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1220.20 -27.70 (-2.22%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.